FIRMQUARRYResearch workspace

GOVERNMENT CONTRACT / DELIVERY ORDER

NIH NHLBI DIR CB A. CAMPBELL LAB REQUIRES PART-TIME MRI TECH IN ORDER TO CONTINUE CLINICAL AND RESEARCH OPERATIONS [23-001902]

Awarded to ASTRIX TECHNOLOGY LLC

PIID 75N92023F00022US · USAspendingResearch & Science
$3.8K
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$3,787sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateNov 1, 2022
Company legal name
ASTRIX TECHNOLOGY LLC
UEI / CAGE
NRVNN8E6NCK4 / Not reported
Parent award
Not reported
Awarding agency
Department of Health and Human Services
Subagency
National Institutes of Health
Industry
Research & Science
NAICS
541712
PSC
R499
Performance period
Not reported — Not reported
Recipient address
125 HALF MILE RD STE 200, RED BANK, MONMOUTH, NJ, 07701
Place of performance
RED BANK, MONMOUTH, NJ, 07701
Source last modified
Nov 3, 2026

Description

NIH NHLBI DIR CB A. CAMPBELL LAB REQUIRES PART-TIME MRI TECH IN ORDER TO CONTINUE CLINICAL AND RESEARCH OPERATIONS [23-001902]

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    NIH NHLBI DIR CB A. CAMPBELL LAB REQUIRES PART-TIME MRI TECH IN ORDER TO CONTINUE CLINICAL AND RESEARCH OPERATIONS [23-001902]

    US · usaspendingSource ↗
  2. Value increased

    NIH NHLBI DIR CB A. CAMPBELL LAB REQUIRES PART-TIME MRI TECH IN ORDER TO CONTINUE CLINICAL AND RESEARCH OPERATIONS [23-001902]

    US · usaspending$3.8KSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Nov 1, 20220Not reported$3,787.20Not reportedNot reportedNIH NHLBI DIR CB A. CAMPBELL LAB REQUIRES PART-TIME MRI TECH IN ORDER TO CONTINUE CLINICAL AND RESEARCH OPERATIONS [23-001902]USAspending ↗